Metagenomi Therapeutics (MGX) Cash & Equivalents (2023 - 2026)
Metagenomi Therapeutics (MGX) reported Cash & Equivalents of $39.03 million for Q2 2026, up 45.4% from $26.85 million a year earlier and up 54.2% from the prior quarter.
Powered by 
Analysis
Metagenomi Therapeutics (MGX) Cash & Equivalents (2023 - 2026) Analysis & Trends
At the end of FY2025, Metagenomi Therapeutics posted Cash & Equivalents of $41.72 million, up 52.3% from FY2024.
- By year, Cash & Equivalents came in at $27.39 million in FY2024 (-80.5%) and $140.6 million in FY2023.
- Five-year quarterly Cash & Equivalents spans a low of $25.12 million in Q3 2024 and a high of $140.6 million in Q4 2023.
- Year over year, Cash & Equivalents gained in three of the last eight quarters, with an average decline of 21.1%.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2025 (growth of 52.3%); the low point was Q4 2024 (a decline of 80.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $25.31 million (Q1 2026), $41.72 million (Q4 2025) and $32.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Metagenomi Therapeutics | 41.93 Mn | 41.93 Mn | - | 39.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.03 Mn |
| Mar 31, 2026 | 25.31 Mn |
| Dec 31, 2025 | 41.72 Mn |
| Sep 30, 2025 | 32.77 Mn |
| Jun 30, 2025 | 26.85 Mn |
| Mar 31, 2025 | 29.20 Mn |
| Dec 31, 2024 | 27.39 Mn |
| Sep 30, 2024 | 25.12 Mn |
| Jun 30, 2024 | 61.18 Mn |
| Mar 31, 2024 | 102.56 Mn |
| Dec 31, 2023 | 140.60 Mn |
| Sep 30, 2023 | 101.90 Mn |
| Jun 30, 2023 | 51.65 Mn |
| Mar 31, 2023 | 95.67 Mn |
API Access
Metagenomi Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();